Ad
related to: treatment of ibd in children- SBS Challenges
Learn more about the clinical
complications of SBS.
- Resources
Explore useful HCP resources
about short bowel syndrome.
- Stay Connected
Sign up to stay informed about
Short Bowel Syndrome
- SBS Overview
Discover information about SBS.
Learn more today.
- SBS Challenges
Search results
Results from the WOW.Com Content Network
Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine, with Crohn's disease and ulcerative colitis (UC) being the principal types. [3] Crohn's disease affects the small intestine and large intestine, as well as the mouth, esophagus, stomach and the anus, whereas UC primarily affects the colon ...
The anti-TNF-α monoclonal antibody infliximab is a major biological therapy for inflammatory bowel disease. Biological therapy, the use of medications called biopharmaceuticals or biologics that are tailored to specifically target an immune or genetic mediator of disease, plays a major role in the treatment of inflammatory bowel disease. [1]
The Crohn's & Colitis Foundation (The Foundation) is a volunteer fueled non-profit organization in the US that works to fund research to find cures for Crohn's disease and ulcerative colitis, collectively known as inflammatory bowel disease (IBD), and to improve the quality of life of children and adults affected by these digestive diseases.
[22] [23] Inflammatory bowel disease resulted in 47,400 deaths in 2015, [24] and those with Crohn's disease have a slightly reduced life expectancy. [1] It tends to start in adolescence and young adulthood, though it can occur at any age. [25] [1] [3] [26] Males and females are equally affected. [3]
A combination of azathioprine and infliximab treatment may be more effective than a single dose of infliximab to induce steroid-free remission for people with active Crohn's disease. [9] Azathioprine treatment may lead to rare but life-threatening side effects. The rare side effects include leukopenia or pancreatitis. [9]
The primary treatment of gastroenteritis in both children and adults is rehydration. This is preferably achieved by drinking rehydration solution, although intravenous delivery may be required if there is a decreased level of consciousness or if dehydration is severe.
Following her residency and fellowship, Oliva-Hemker joined the Johns Hopkins faculty in 1993. During her early years with the institution, she launched the Pediatric Inflammatory Bowel Disease (IBD) Center at Johns Hopkins, which specializes in the evaluation, diagnosis, and treatment of children and teens with Crohn's disease and ulcerative colitis. [4]
Pharmacological treatment for children with functional constipation consists of maintenance therapy and faecal disimpaction. High-dose oral polyethylene glycol (PEG) or enemas containing active substances can induce fecal disimpaction, while maintenance therapy is recommended after successful disimpaction to avoid reoccurring stool buildup.
Ad
related to: treatment of ibd in children